09.30.15
Pocketderm—an online service that offers customized prescription creams for acne and anti-aging—has relaunched as Curology.
Founded by dermatologist Dr. David Lortscher, the firm partners patients with licensed healthcare professionals and custom-formulates medications at its laboratory in San Diego, CA.
"Prescription medications are highly effective for treating acne and wrinkles. But so many people can't spend the time required to visit a doctor's office and a pharmacy," said Dr. Lortscher. "So we built an end-to-end personalized experience that makes it simple to achieve clear, healthy and youthful skin."
Patients are paired online with a licensed dermatologist or nurse practitioner who evaluates photos of the patient's skin, prescribes a medication tailored for their skin type and becomes their long-term partner in achieving their skincare goals. The treatments shipped to their door and have access to unlimited communication with their healthcare provider via a secure messaging platform.
Curology has also banked $4.2 million in funding from Sherpa Capital, known for investments in Munchery, Uber and Ipsy, and from Forerunner Ventures, whose portfolio includes Warby Parker, Birchbox and Glossier.
This first institutional round of funding will allow Curology to scale its medical team and continue investing in research and development of customized prescription skincare.
Curology debuted in 2014 under the name PocketDerm and initially treated only acne. It is currently available in 40 states.
Founded by dermatologist Dr. David Lortscher, the firm partners patients with licensed healthcare professionals and custom-formulates medications at its laboratory in San Diego, CA.
"Prescription medications are highly effective for treating acne and wrinkles. But so many people can't spend the time required to visit a doctor's office and a pharmacy," said Dr. Lortscher. "So we built an end-to-end personalized experience that makes it simple to achieve clear, healthy and youthful skin."
Patients are paired online with a licensed dermatologist or nurse practitioner who evaluates photos of the patient's skin, prescribes a medication tailored for their skin type and becomes their long-term partner in achieving their skincare goals. The treatments shipped to their door and have access to unlimited communication with their healthcare provider via a secure messaging platform.
Curology has also banked $4.2 million in funding from Sherpa Capital, known for investments in Munchery, Uber and Ipsy, and from Forerunner Ventures, whose portfolio includes Warby Parker, Birchbox and Glossier.
This first institutional round of funding will allow Curology to scale its medical team and continue investing in research and development of customized prescription skincare.
Curology debuted in 2014 under the name PocketDerm and initially treated only acne. It is currently available in 40 states.